Some Cancer Patients 'Hyperprogress' on Immunotherapy
One patient with MDM2 amplification assessed at the UC San Diego Center for Personalized Cancer Therapy was a 65-year-old woman whose endometrial stromal sarcoma progressed quickly on nivolumab, an anti-programmed death 1 (PD-1) monoclonal antibody immunotherapy. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- cancer lymph node on ultrasound
- immunotherapy cancer treatment centers
- immunotherapy for cancer treatment
- immunotherapy and cancer treatment
- immunotherapy for lung cancer 2019
- immunotherapy lung cancer latest news
- immunotherapy cancer treatment
- immunotherapy lung cancer survival rate
- immunotherapy for lung cancer prognosis
- immunotherapy bladder cancer side effects
- bladder cancer immunotherapy treatment
- immunotherapy for bladder cancer updates